Sibğatullah Ali Orak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sibğatullah Ali Orak has a total of 131 co-authors. Here are the top co-authors by number of shared publications:
- Çisil Çerçi Kubur
Celal Bayar Üniversitesi
15 shared publications - Muzaffer Polat
Celal Bayar Üniversitesi
14 shared publications - Aslı Kübra Atasever
Department of Pediatric Neurology, Manisa Celal Bayar University
9 shared publications - Celil Yılmaz
Department of Pediatric Neurology, Celal Bayar University, Faculty of Medicine, Manisa, Türkiye
7 shared publications - Beyhan Cengiz Özyurt
Celal Bayar University, Faculty of Medicine, Department of Public Health, Manisa, Turkey
4 shared publications Muzaffer Polat
Manisa Celal Bayar University, Turkey
4 shared publications
Latest Publications
- 22 October 2026
- Published by Elsevier in Epilepsy & Behavior
- Vol. 186, 111353
Parenting stress and life satisfaction among caregivers of children and adolescents with Epilepsy: A cross-sectional case-control study
- 22 October 2026
- Published by Elsevier in Epilepsy & Behavior
- Vol. 186, 111353
Parenting stress and life satisfaction among caregivers of children and adolescents with Epilepsy: A cross-sectional case-control study
- 18 August 2026
- Published by Taylor & Francis in Applied Neuropsychology: Child
- p. 1-9
Electrophysiological, neurocognitive, and GFAP biomarker responses to corticosteroid therapy in children with ESES/CSWS
Electrical status epilepticus during slow-wave sleep (ESES) is a childhood-onset epilepsy syndrome characterized by prominent epileptiform activity during non-rapid eye movement sleep and is freque...
- 18 August 2026
- Published by Taylor & Francis in Applied Neuropsychology: Child
- p. 1-9
Electrophysiological, neurocognitive, and GFAP biomarker responses to corticosteroid therapy in children with ESES/CSWS
Electrical status epilepticus during slow-wave sleep (ESES) is a childhood-onset epilepsy syndrome characterized by prominent epileptiform activity during non-rapid eye movement sleep and is freque...
- 16 July 2026
- Published by Taylor & Francis in Applied Neuropsychology: Child
- p. 1-9
Cognitive disengagement syndrome and learning difficulty symptoms in children with epilepsy: A case–control study
Sluggish cognitive tempo (SCT)—increasingly referred to as Cognitive Disengagement Syndrome (CDS) in recent literature (Becker et al., 2023; Becker, 2020; Auvin et al., 2018)—is an emerging attenti...
- 16 July 2026
- Published by Taylor & Francis in Applied Neuropsychology: Child
- p. 1-9
Cognitive disengagement syndrome and learning difficulty symptoms in children with epilepsy: A case–control study
Sluggish cognitive tempo (SCT)—increasingly referred to as Cognitive Disengagement Syndrome (CDS) in recent literature (Becker et al., 2023; Becker, 2020; Auvin et al., 2018)—is an emerging attenti...
- 9 June 2026
- Published by Georg Thieme Verlag KG in Neuropediatrics
- Vol. 57 (04) , 267-272
Clinical, Radiological, and Prognostic Features of Pediatric Clinically Isolated Syndrome and Risk of Conversion to Multiple Sclerosis: A Single-center Cohort Study
Pediatric clinically isolated syndrome (CIS) is the first inflammatory demyelinating event of the central nervous system and may progress to multiple sclerosis (MS). Data on relapse patterns and predictors of MS conversion in children remain limited. To evaluate the clinical, radiological, and immunological characteristics of pediatric CIS and to identify factors associated with relapse and final diagnosis. In this retrospective cohort study, pediatric patients (3–18 years) presenting with a first demyelinating event between 2011 and 2021 were included if follow-up was ≥6 months. Clinical, MRI, laboratory, and immunological data were reviewed. Group comparisons were performed using non-parametric tests. Relapse predictors were explored using penalized logistic regression. A total of 26 patients were included (mean age 13.2 ± 3.2 years; 14 male). Optic neuritis was the most common presentation (57.7%). During a mean follow-up of 1.28 ± 1.31 years, 30.8% were diagnosed with MS. Relapse occurred in 42% of patients and differed significantly across diagnostic groups (p < 0.001). EDSS scores improved significantly at 3 months (mean reduction 1.79 ± 0.92; p < 0.001). NMO/MOG seropositivity was associated with final diagnosis (p = 0.015). Oligoclonal band positivity showed an increased odds ratio for relapse (OR 7.22) but was not statistically significant. No independent relapse predictors were identified. Approximately one-third of pediatric CIS patients converted to MS. Relapse patterns differed across diagnostic groups. Although immunological markers may indicate increased relapse risk, larger prospective studies are required to define independent predictors of MS conversion.
- 9 June 2026
- Published by Georg Thieme Verlag KG in Neuropediatrics
- Vol. 57 (04) , 267-272
Clinical, Radiological, and Prognostic Features of Pediatric Clinically Isolated Syndrome and Risk of Conversion to Multiple Sclerosis: A Single-center Cohort Study
Pediatric clinically isolated syndrome (CIS) is the first inflammatory demyelinating event of the central nervous system and may progress to multiple sclerosis (MS). Data on relapse patterns and predictors of MS conversion in children remain limited. To evaluate the clinical, radiological, and immunological characteristics of pediatric CIS and to identify factors associated with relapse and final diagnosis. In this retrospective cohort study, pediatric patients (3–18 years) presenting with a first demyelinating event between 2011 and 2021 were included if follow-up was ≥6 months. Clinical, MRI, laboratory, and immunological data were reviewed. Group comparisons were performed using non-parametric tests. Relapse predictors were explored using penalized logistic regression. A total of 26 patients were included (mean age 13.2 ± 3.2 years; 14 male). Optic neuritis was the most common presentation (57.7%). During a mean follow-up of 1.28 ± 1.31 years, 30.8% were diagnosed with MS. Relapse occurred in 42% of patients and differed significantly across diagnostic groups (p < 0.001). EDSS scores improved significantly at 3 months (mean reduction 1.79 ± 0.92; p < 0.001). NMO/MOG seropositivity was associated with final diagnosis (p = 0.015). Oligoclonal band positivity showed an increased odds ratio for relapse (OR 7.22) but was not statistically significant. No independent relapse predictors were identified. Approximately one-third of pediatric CIS patients converted to MS. Relapse patterns differed across diagnostic groups. Although immunological markers may indicate increased relapse risk, larger prospective studies are required to define independent predictors of MS conversion.
- Open Access
- 25 March 2026
- Published by Baycinar Tibbi Yayincilik in Journal of Parkinson’s Disease and Movement Disorders
- Vol. 29 (1) , 10-14
Retrospective evaluation of patients followed with a diagnosis of dystonia: A single-center experience
Background: This study aimed to evaluate the clinical and etiological characteristics of pediatric patients followed with a diagnosis of dystonia at a tertiary pediatric neurology center. Materials and Methods: Patients under the age of 18 who presented to our clinic between January 1, 2011, and December 31, 2021, and had a diagnosis or a preliminary diagnosis of dystonia in their records were included. Demographic data, clinical findings, laboratory and imaging results, genetic analyses, and treatment responses of the patients were retrospectively reviewed. Results: A total of 32 patients with dystonia were included in the study. The mean age of the patients was 11 years (range: 1-17 years), with 12 females and 20 males. Secondary dystonia was the most common etiological group, with drug-induced dystonias being particularly prominent within this subgroup. Clinical benefit was achieved with botulinum toxin treatment in selected cases. Conclusion: Childhood dystonias encompass a broad etiological spectrum. Comprehensive clinical evaluation and accurate classification are crucial for identifying the underlying cause and planning effective therapeutic interventions.
- 25 March 2026
- Published by Baycinar Tibbi Yayincilik in Journal of Parkinson’s Disease and Movement Disorders
- Vol. 29 (1) , 10-14
Open AccessRetrospective evaluation of patients followed with a diagnosis of dystonia: A single-center experience
Background: This study aimed to evaluate the clinical and etiological characteristics of pediatric patients followed with a diagnosis of dystonia at a tertiary pediatric neurology center. Materials and Methods: Patients under the age of 18 who presented to our clinic between January 1, 2011, and December 31, 2021, and had a diagnosis or a preliminary diagnosis of dystonia in their records were included. Demographic data, clinical findings, laboratory and imaging results, genetic analyses, and treatment responses of the patients were retrospectively reviewed. Results: A total of 32 patients with dystonia were included in the study. The mean age of the patients was 11 years (range: 1-17 years), with 12 females and 20 males. Secondary dystonia was the most common etiological group, with drug-induced dystonias being particularly prominent within this subgroup. Clinical benefit was achieved with botulinum toxin treatment in selected cases. Conclusion: Childhood dystonias encompass a broad etiological spectrum. Comprehensive clinical evaluation and accurate classification are crucial for identifying the underlying cause and planning effective therapeutic interventions.
- 12 March 2026
- Published by Elsevier in Epilepsy & Behavior
- Vol. 179, 110998
Electrocardiographic repolarization and conduction abnormalities in pediatric epilepsy
- 12 March 2026
- Published by Elsevier in Epilepsy & Behavior
- Vol. 179, 110998
Electrocardiographic repolarization and conduction abnormalities in pediatric epilepsy
- Open Access
- 1 August 2025
- Published by Baycinar Tibbi Yayincilik in Journal of Parkinson’s Disease and Movement Disorders
- Vol. 28 (2-3) , 36-40
Acute cerebellitis in SARS-CoV-2 infection: A case report
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first identified in Wuhan, China, in December 2019, has emerged as a major global public health threat. The literature on the severe neurological manifestations of coronavirus disease 2019 (COVID-19) has expanded substantially, with numerous studies and reviews documenting a wide spectrum of neurologic involvement. Nevertheless, COVID-19-associated cerebellitis in infants without accompanying systemic symptoms has not been previously described. Herein, we reported the case of a 12-month-old patient who presented with acute ataxia and was diagnosed with COVID-19-associated acute cerebellitis based on characteristic magnetic resonance imaging findings. The patient demonstrated notable clinical improvement following a five-day course of intravenous immunoglobulin. This case highlights the potential of SARS-CoV-2 to mimic diverse neurologic presentations, even in the absence of systemic manifestations, and underscores the importance of maintaining a high index of suspicion for COVID-19 in infants presenting with acute cerebellar dysfunction.
- 1 August 2025
- Published by Baycinar Tibbi Yayincilik in Journal of Parkinson’s Disease and Movement Disorders
- Vol. 28 (2-3) , 36-40
Open AccessAcute cerebellitis in SARS-CoV-2 infection: A case report
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first identified in Wuhan, China, in December 2019, has emerged as a major global public health threat. The literature on the severe neurological manifestations of coronavirus disease 2019 (COVID-19) has expanded substantially, with numerous studies and reviews documenting a wide spectrum of neurologic involvement. Nevertheless, COVID-19-associated cerebellitis in infants without accompanying systemic symptoms has not been previously described. Herein, we reported the case of a 12-month-old patient who presented with acute ataxia and was diagnosed with COVID-19-associated acute cerebellitis based on characteristic magnetic resonance imaging findings. The patient demonstrated notable clinical improvement following a five-day course of intravenous immunoglobulin. This case highlights the potential of SARS-CoV-2 to mimic diverse neurologic presentations, even in the absence of systemic manifestations, and underscores the importance of maintaining a high index of suspicion for COVID-19 in infants presenting with acute cerebellar dysfunction.
- Open Access
- 2 June 2025
- Published by Wiley in Headache: The Journal of Head and Face Pain
- Vol. 65 (10) , 1821-1830
Can serum neuropeptide levels help diagnose pediatric migraine? A prospective case–control study
Objective: The objective of this study was to examine the serum levels of vasoactive neuropeptides (calcitonin gene‐related peptide [CGRP], pituitary adenylate cyclase‐activating peptide‐38 [PACAP‐38], substance P [SP], and vasoactive intestinal peptide [VIP], which have been linked to the pathophysiology of migraine in adults) in pediatric migraine without aura during both pain attacks and pain‐free periods and in a control group, with a view of evaluating their diagnostic value in pediatric migraine. Background: The diagnosis of migraine is based on clinical features described by patients and pediatric patients may not be able to express migraine symptoms as clearly as adults. The fact that objective biological markers of migraine have not yet been fully defined makes diagnosis difficult, especially in children. Methods: This prospective cross‐sectional case–control study included 39 children and adolescents (aged 8–18 years) diagnosed with migraine without aura and 40 healthy control children between May 2022 and March 2023. The 39 patients with migraine were evaluated both during the course of their migraine attacks and during periods of pain‐free status. Plasma vasoactive peptides were measured using an enzyme‐linked immunosorbent assay. Results: The comparison of serum SP, PACAP‐38, and CGRP neuropeptide levels in the 39 patients with migriane during the ictal and interictal periods revealed no significant differences between the two periods. VIP neuropeptide levels in the ictal period (mean [standard deviation, SD] 291.6 [118.5] pg/mL) in the migraine cohort were found to be significantly higher than the levels observed in both the interictal (mean [SD] 263.6 [100.9] pg/mL, p = 0.019) and healthy control groups (mean [SD] 229.7 [109.3] pg/mL, p = 0.018) ( p < 0.05). The level of the neuropeptide SP (mean [SD] 150.5 [29] pg/mL) in the interictal period was found to be lower than that observed in the healthy control group (mean [SD] 174.6 [39.4] pg/mL, p = 0.030) ( p < 0.05). Furthermore, the CGRP level in the interictal period (mean [SD] 395.6 [197.6] pg/mL) was found to be significantly higher than that observed in the healthy control group (mean [SD] 320.3 [126.6] pg/mL, p = 0.049) ( p < 0.05). No significant differences were observed in the levels of the other neuropeptides. Conclusions: The present study revealed elevated VIP levels during the ictal period and elevated CGRP levels during the interictal period in patients with migraine without aura when compared to controls. In addition, VIP serum levels were significantly higher in the ictal period compared to both the interictal period and healthy controls. The findings of our study lend support to the use of these neuropeptides as biomarkers for migraine. Nevertheless, further studies and standardization are necessary to ascertain the diagnostic value of single or combinations of SP, PACAP‐38, VIP, and CGRP neuropeptides in diagnosing pediatric migraine and differentiating pediatric migraine from non‐migraine headaches.
- 2 June 2025
- Published by Wiley in Headache: The Journal of Head and Face Pain
- Vol. 65 (10) , 1821-1830
Open AccessCan serum neuropeptide levels help diagnose pediatric migraine? A prospective case–control study
Objective: The objective of this study was to examine the serum levels of vasoactive neuropeptides (calcitonin gene‐related peptide [CGRP], pituitary adenylate cyclase‐activating peptide‐38 [PACAP‐38], substance P [SP], and vasoactive intestinal peptide [VIP], which have been linked to the pathophysiology of migraine in adults) in pediatric migraine without aura during both pain attacks and pain‐free periods and in a control group, with a view of evaluating their diagnostic value in pediatric migraine. Background: The diagnosis of migraine is based on clinical features described by patients and pediatric patients may not be able to express migraine symptoms as clearly as adults. The fact that objective biological markers of migraine have not yet been fully defined makes diagnosis difficult, especially in children. Methods: This prospective cross‐sectional case–control study included 39 children and adolescents (aged 8–18 years) diagnosed with migraine without aura and 40 healthy control children between May 2022 and March 2023. The 39 patients with migraine were evaluated both during the course of their migraine attacks and during periods of pain‐free status. Plasma vasoactive peptides were measured using an enzyme‐linked immunosorbent assay. Results: The comparison of serum SP, PACAP‐38, and CGRP neuropeptide levels in the 39 patients with migriane during the ictal and interictal periods revealed no significant differences between the two periods. VIP neuropeptide levels in the ictal period (mean [standard deviation, SD] 291.6 [118.5] pg/mL) in the migraine cohort were found to be significantly higher than the levels observed in both the interictal (mean [SD] 263.6 [100.9] pg/mL, p = 0.019) and healthy control groups (mean [SD] 229.7 [109.3] pg/mL, p = 0.018) ( p < 0.05). The level of the neuropeptide SP (mean [SD] 150.5 [29] pg/mL) in the interictal period was found to be lower than that observed in the healthy control group (mean [SD] 174.6 [39.4] pg/mL, p = 0.030) ( p < 0.05). Furthermore, the CGRP level in the interictal period (mean [SD] 395.6 [197.6] pg/mL) was found to be significantly higher than that observed in the healthy control group (mean [SD] 320.3 [126.6] pg/mL, p = 0.049) ( p < 0.05). No significant differences were observed in the levels of the other neuropeptides. Conclusions: The present study revealed elevated VIP levels during the ictal period and elevated CGRP levels during the interictal period in patients with migraine without aura when compared to controls. In addition, VIP serum levels were significantly higher in the ictal period compared to both the interictal period and healthy controls. The findings of our study lend support to the use of these neuropeptides as biomarkers for migraine. Nevertheless, further studies and standardization are necessary to ascertain the diagnostic value of single or combinations of SP, PACAP‐38, VIP, and CGRP neuropeptides in diagnosing pediatric migraine and differentiating pediatric migraine from non‐migraine headaches.
- Open Access
- 26 March 2025
- Published by Celal Bayar Universitesi Saglık Bilimleri Enstitusu Dergisi in Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi
- Vol. 12 (1) , 29-36
Tuberoskleroz Tanısı ile İzlenen Hastaların Klinik Özellikleri: Tek Merkez Deneyimi
Özet Amaç: Nörokutanöz sendromlar sinir sistemini, cildi tutan hastalık grubudur. Bunların arasında en sık görülenlerden biri de tuberoskleroz’dur (TS). Bu çalışmanın amacı Celal Bayar Üniversitesi Çocuk Nörolojisi Polikliniğinde izlenen TS tanılı hastaların klinik özelliklerini değerlendirmektir. Gereç ve Yöntemler: Ocak 2005-Ocak 2023 tarihleri arasında TS tanılı toplam 23 hastanın dosya kayıtları geriye dönük olarak gözden geçirildi. Bulgular : Hastaların 9’u (%39) erkek, 14’ü (%61) kızdı. 1 hastada (%0,05) aile öyküsü mevcuttu. Hastaların hepsinde (%100) TS geninde mutasyon saptanmıştı. Hastaların tamamında hipomelanotik makül lekeleri mevcutken, shagren patch 4 hastada (%17), anjiofibroma 5 hastada (%21) rastlandı. 11 hastada (%47) kognitif bozukluklar, 11 hastada (%47) epilepsi vardı. Tartışma ve Sonuç: TS sinir sistemi, cilt gibi bir çok sistem tutulumu yapan geniş yelpazeli bir hastalıktır. Hastalar çok farklı klinik bulgular ile karşımıza çıkabilir. Epilepsi, öğrenme güçlüğü gibi nonspesifik yakınmalarla çocuk nörolojisi polikliniğine başvuran hastalar dikkatli bir göz ve deri muayenesi ile TS tanısı alabilir. Hastalığın klinik özelliklerinin sıklığının bilinmesi tanı konulmasında yardımcı olacaktır.
- 26 March 2025
- Published by Celal Bayar Universitesi Saglık Bilimleri Enstitusu Dergisi in Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi
- Vol. 12 (1) , 29-36
Open AccessTuberoskleroz Tanısı ile İzlenen Hastaların Klinik Özellikleri: Tek Merkez Deneyimi
Özet Amaç: Nörokutanöz sendromlar sinir sistemini, cildi tutan hastalık grubudur. Bunların arasında en sık görülenlerden biri de tuberoskleroz’dur (TS). Bu çalışmanın amacı Celal Bayar Üniversitesi Çocuk Nörolojisi Polikliniğinde izlenen TS tanılı hastaların klinik özelliklerini değerlendirmektir. Gereç ve Yöntemler: Ocak 2005-Ocak 2023 tarihleri arasında TS tanılı toplam 23 hastanın dosya kayıtları geriye dönük olarak gözden geçirildi. Bulgular : Hastaların 9’u (%39) erkek, 14’ü (%61) kızdı. 1 hastada (%0,05) aile öyküsü mevcuttu. Hastaların hepsinde (%100) TS geninde mutasyon saptanmıştı. Hastaların tamamında hipomelanotik makül lekeleri mevcutken, shagren patch 4 hastada (%17), anjiofibroma 5 hastada (%21) rastlandı. 11 hastada (%47) kognitif bozukluklar, 11 hastada (%47) epilepsi vardı. Tartışma ve Sonuç: TS sinir sistemi, cilt gibi bir çok sistem tutulumu yapan geniş yelpazeli bir hastalıktır. Hastalar çok farklı klinik bulgular ile karşımıza çıkabilir. Epilepsi, öğrenme güçlüğü gibi nonspesifik yakınmalarla çocuk nörolojisi polikliniğine başvuran hastalar dikkatli bir göz ve deri muayenesi ile TS tanısı alabilir. Hastalığın klinik özelliklerinin sıklığının bilinmesi tanı konulmasında yardımcı olacaktır.
- 21 September 2024
- Published by Academician Publishing
- p. 347-352
Değişken Odaklı Familyal Fokal Epilepsi (Çocukluktan Erişkin Döneme Kadar)
Değişken odaklara sahip ailesel fokal epilepsi (FFEVF), fokal epilepsili birden fazla aile üyesi ile karakterize, nöbet odağının aile üyeleri arasında farklılık gösterebilen ancak aynı bireyde sabit kaldığı ailesel epilepsi sendromudur. Değişken odaklı ailesel fokal epilepsi genetik nedenli epilepsi sendromları arasında yer almaktadır. Genetik tanılaması ilk olarak 1999 yılında 22. Kromozomda haritalanmıştır ve sorumlu gen olan DEPDC5, 2013 yılında ekzom dizileme yoluyla tanımlanmıştır. Bu epilepsi sendromu yaklaşık %70 penetrans ile otozomal dominant kalıtım paterni gösterir. Değişken odaklara sahip bu sendrom, Uluslararası Epilepsiye Karşı Savaş Derneği tarafından da epileptik sendromların sınıflandırılması tanı şemasına dahil edilmiştir.Nöbetin başlama zamanı bebeklikten erişkin döneme kadar başlayabilir ve şiddeti aile üyeleri arasında önemli ölçüde değişebilir ve bazıları komorbid nöro-psikiyatrik belirtiler sergileyebilirler. Epileptik nöbetler gündüz, gece veya her ikisinde birden görülebilir ve sıklıkla frontal veya temporal loblardan kaynaklanır, ancak bazen oksipital veya paryetal loblardan da kaynaklanabilir. Değişken odaklı ailesel fokal epilepsi sendromu ancak aile öyküsü olan hastalarda tanımlanabilir. Hastanın akrabalarında en az 2 farklı fokal epilepsi sendromunun varlığı ve birden fazla kuşakta benzer klinikte hasta tanımlanması FFEVF’yi düşündürebilir. Bununla birlikte, tanı ve kalıtım paterninin doğrulanamadığı birçok aile, değişken odaklı ailesel fokal epilepsiyle ilişkili ortak varyantları taşımaktadır.
- 21 September 2024
- Published by Academician Publishing
- p. 347-352
Değişken Odaklı Familyal Fokal Epilepsi (Çocukluktan Erişkin Döneme Kadar)
Değişken odaklara sahip ailesel fokal epilepsi (FFEVF), fokal epilepsili birden fazla aile üyesi ile karakterize, nöbet odağının aile üyeleri arasında farklılık gösterebilen ancak aynı bireyde sabit kaldığı ailesel epilepsi sendromudur. Değişken odaklı ailesel fokal epilepsi genetik nedenli epilepsi sendromları arasında yer almaktadır. Genetik tanılaması ilk olarak 1999 yılında 22. Kromozomda haritalanmıştır ve sorumlu gen olan DEPDC5, 2013 yılında ekzom dizileme yoluyla tanımlanmıştır. Bu epilepsi sendromu yaklaşık %70 penetrans ile otozomal dominant kalıtım paterni gösterir. Değişken odaklara sahip bu sendrom, Uluslararası Epilepsiye Karşı Savaş Derneği tarafından da epileptik sendromların sınıflandırılması tanı şemasına dahil edilmiştir.Nöbetin başlama zamanı bebeklikten erişkin döneme kadar başlayabilir ve şiddeti aile üyeleri arasında önemli ölçüde değişebilir ve bazıları komorbid nöro-psikiyatrik belirtiler sergileyebilirler. Epileptik nöbetler gündüz, gece veya her ikisinde birden görülebilir ve sıklıkla frontal veya temporal loblardan kaynaklanır, ancak bazen oksipital veya paryetal loblardan da kaynaklanabilir. Değişken odaklı ailesel fokal epilepsi sendromu ancak aile öyküsü olan hastalarda tanımlanabilir. Hastanın akrabalarında en az 2 farklı fokal epilepsi sendromunun varlığı ve birden fazla kuşakta benzer klinikte hasta tanımlanması FFEVF’yi düşündürebilir. Bununla birlikte, tanı ve kalıtım paterninin doğrulanamadığı birçok aile, değişken odaklı ailesel fokal epilepsiyle ilişkili ortak varyantları taşımaktadır.